当前位置: X-MOL 学术Mult. Scler. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)
Multiple Sclerosis Journal ( IF 4.8 ) Pub Date : 2020-05-04 , DOI: 10.1177/1352458520918377
Jan D Lünemann 1 , Judit Diaz-Diaz 2 , Bruno Stankoff 3 , Carolyn Young 4 , Aksel Siva 5 , Aaron Miller 6 , Catherine Lubetzki 3 , Heinz Wiendl 1 , Celia Oreja-Guevara 7
Affiliation  

The 2019 ECTRIMS Congress, in Stockholm, has had record-breaking figures for both attendance and scientific production. There were 9361 participants from 100 different countries for a total of 1541 abstracts. Upon invitation of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) executive committee, the authors of this meeting report assessed abstracts from all poster and oral presentations for novelty, scientific quality and relevance for basic and clinical multiple sclerosis (MS) research. The objective of this report is to highlight a selection of basic, translational and clinical studies out of the many outstanding projects that were presented. Abstracts and references cited in our report were chosen at the discretion of the authors and all co-authors and the ECTRIMS executive committee agreed on the selection. In the event of discrepancies between the abstract and the uploaded poster or presentation, we aimed to present data derived from the poster or presentation. All abstracts are accessible through the ECTRIMS online library (https://onlinelibrary.ectrimscongress.eu/ectrims/#!*menu=36*browseby=3*sortby=2*ce_id=160) and also published in this journal (Volume 25 Issue 2_suppl, September 2019; https://journals.sagepub.com/toc/msja/25/2_suppl). A few additional references from the literature were added but were restricted to the ones that authors considered as absolutely required for an optimized understanding of the topics highlighted.

中文翻译:

2019 年欧洲多发性硬化症治疗和研究大会 (ECTRIMS 2019) 的亮点

2019 年在斯德哥尔摩举行的 ECTRIMS 大会在出席人数和科学产出方面都创下了破纪录的数字。来自 100 个不同国家的 9361 名参与者共收到 1541 篇摘要。应欧洲多发性硬化症治疗和研究委员会 (ECTRIMS) 执行委员会的邀请,本会议报告的作者评估了所有海报和口头报告摘要的新颖性、科学质量以及与基础和临床多发性硬化症 (MS) 研究的相关性. 本报告的目的是从许多已提交的优秀项目中选出一些基础、转化和临床研究。我们报告中引用的摘要和参考文献是由作者和所有合著者自行决定选择的,ECTRIMS 执行委员会同意选择。如果摘要与上传的海报或演示文稿之间存在差异,我们旨在展示来自海报或演示文稿的数据。所有摘要均可通过 ECTRIMS 在线图书馆 (https://onlinelibrary.ectrimscongress.eu/ectrims/#!*menu=36*browseby=3*sortby=2*ce_id=160) 访问,并发表在本期刊上(第 25 卷)第 2 期_suppl,2019 年 9 月;https://journals.sagepub.com/toc/msja/25/2_suppl)。添加了一些来自文献的其他参考文献,但仅限于作者认为对于优化理解突出显示的主题绝对需要的参考文献。所有摘要均可通过 ECTRIMS 在线图书馆 (https://onlinelibrary.ectrimscongress.eu/ectrims/#!*menu=36*browseby=3*sortby=2*ce_id=160) 访问,并发表在本期刊上(第 25 卷)第 2 期_suppl,2019 年 9 月;https://journals.sagepub.com/toc/msja/25/2_suppl)。添加了一些来自文献的其他参考文献,但仅限于作者认为对于优化理解突出显示的主题绝对需要的参考文献。所有摘要均可通过 ECTRIMS 在线图书馆 (https://onlinelibrary.ectrimscongress.eu/ectrims/#!*menu=36*browseby=3*sortby=2*ce_id=160) 访问,并发表在本期刊上(第 25 卷)第 2 期_suppl,2019 年 9 月;https://journals.sagepub.com/toc/msja/25/2_suppl)。添加了一些来自文献的其他参考文献,但仅限于作者认为对于优化理解突出显示的主题绝对需要的参考文献。
更新日期:2020-05-04
down
wechat
bug